MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-13-2026
FONAR Corporation Accounts Receivables 2011-2026 | FONR
Accounts receivable — is the amount of money owed to a company by other organizations, individuals, or the government. It arises when a company has already delivered goods, performed work, or provided services, but has not yet received payment for them.Examples of accounts receivable
- Customers have not paid invoices for delivered products
- An advance has been paid to a supplier, but goods have not yet been received
- Employees have not reported on accountable amounts
- The government must refund tax overpayments
- Outstanding loans issued
- Asset quality
Accounts receivable are part of current assets. But they are not cash — they are promises. Investors assess how realistic these promises are to be collected. The higher the share of overdue or doubtful receivables, the greater the risk of asset impairment. - Impact on cash flow
Even if a company shows a profit, the money can be "tied up" in receivables. This means profit does not turn into actual cash, and the company may face liquidity shortages. - Assessment of management efficiency
The following accounts receivable turnover ratios are commonly used:
Receivables turnover = Revenue / Average accounts receivable
(the higher — the better)
Days Sales Outstanding (DSO) = 365 / Turnover
(the fewer days — the faster customers pay)
If the DSO is constantly increasing — this is a red flag — customers are delaying payments, and money gets stuck in settlements.
Quarterly Accounts Receivables FONAR Corporation
| 2025-Q4 | 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.76 M | 5.15 M | 4.6 M | 3.39 M | 3.87 M | 3.31 M | - | - | - | - | - | - | - | - | - | - | - | - | - | 16.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4.44 M | 5.36 M | 5.03 M | 4.44 M | 4.44 M | 4.92 M | 4.91 M | 5.1 M | 5.1 M | 4.82 M | 4.7 M | 5.26 M | 5.26 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 16.2 M | 3.31 M | 5.25 M |
Accounts Receivables of other stocks in the Medical devices industry
| Issuer | Accounts Receivables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
11.4 M | - | -26.83 % | $ 2.62 M |  USA |
 |
AdaptHealth Corp.
AHCO
|
371 M | $ 11.9 | -1.45 % | $ 1.61 B | USA |
 |
Allied Healthcare Products
AHPI
|
2.37 M | - | 3.58 % | $ 2.21 M | USA |
 |
ClearPoint Neuro
CLPT
|
6.55 M | $ 8.95 | -4.64 % | $ 253 M | USA |
 |
Bruker Corporation
BRKR
|
566 M | $ 36.56 | -0.49 % | $ 5.45 K | USA |
 |
Apollo Endosurgery
APEN
|
15 M | - | - | $ 475 M | USA |
 |
Myomo
MYO
|
4.1 M | $ 0.66 | -5.54 % | $ 27.6 M | USA |
 |
EDAP TMS S.A.
EDAP
|
17.9 M | $ 3.42 | -1.16 % | $ 128 M |  France |
 |
Avinger
AVGR
|
1.01 M | - | -20.74 % | $ 369 K | USA |
 |
Align Technology
ALGN
|
996 M | $ 167.26 | -2.69 % | $ 12.5 B | USA |
 |
AxoGen
AXGN
|
26.2 M | $ 30.8 | -5.64 % | $ 1.42 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
44.8 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
1.73 M | - | 1.37 % | $ 20.5 M | USA |
 |
Globus Medical
GMED
|
679 M | $ 89.86 | 1.39 % | $ 12.2 B | USA |
 |
Butterfly Network
BFLY
|
20.8 M | $ 4.02 | -2.9 % | $ 851 M | USA |
 |
Cytosorbents Corporation
CTSO
|
7.55 M | $ 0.58 | -1.27 % | $ 36.1 M | USA |
 |
BIOLASE
BIOL
|
5.48 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
11.7 M | $ 9.64 | -0.62 % | $ 345 M | USA |
 |
BioSig Technologies
BSGM
|
109 K | - | 37.08 % | $ 85.7 M | USA |
 |
Alphatec Holdings
ATEC
|
97.3 M | $ 10.98 | 0.05 % | $ 1.65 B | USA |
 |
CONMED Corporation
CNMD
|
248 M | $ 34.7 | 1.86 % | $ 1.08 B | USA |
 |
Helius Medical Technologies
HSDT
|
117 K | $ 1.82 | -4.21 % | $ 1.11 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
272 M | $ 9.25 | -0.64 % | $ 712 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
660 M | $ 80.79 | -0.44 % | $ 47.2 B | USA |
 |
IRIDEX Corporation
IRIX
|
7.61 M | $ 1.03 | 3.61 % | $ 17.4 M | USA |
 |
Integer Holdings Corporation
ITGR
|
346 M | $ 84.62 | -1.17 % | $ 2.94 B | USA |
 |
Inspire Medical Systems
INSP
|
120 M | $ 53.48 | -1.19 % | $ 1.57 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
53.8 M | $ 15.69 | -1.57 % | $ 368 M | USA |
 |
Conformis
CFMS
|
9.77 M | - | - | $ 16.4 M | USA |
 |
LENSAR
LNSR
|
6.38 M | $ 5.58 | -5.26 % | $ 66.7 M | USA |
 |
Medtronic PLC
MDT
|
6.52 B | $ 86.63 | 0.39 % | $ 111 B | USA |
 |
Cardiovascular Systems
CSII
|
39.7 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
43.1 M | - | -10.19 % | $ 1.99 M | USA |
 |
Dynatronics Corporation
DYNT
|
2.8 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
1.91 M | - | - | $ 10.2 M | USA |
 |
Orthofix Medical
OFIX
|
136 M | $ 11.68 | -0.76 % | $ 463 M |  Curacao |
 |
Second Sight Medical Products
EYES
|
455 K | - | -0.97 % | $ 54.4 M | USA |